Live search
TopFind is fetching the latest matches for your search.
We reviewed 8 live results for amgevita and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologics and Biosimilar.
Source: Amgen Biotechnology Singapore Pte Ltd
Description
Amgevita is a biosimilar to Humira (adalimumab) registered in Singapore for the treatment of various inflammatory conditions, including rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis. As an anti-inflammatory biologic, it provides a high-quality, cost-effective alternative for patients managing chronic autoimmune diseases.
Best for
rheumatoid arthritis patients, plaque psoriasis treatment and cost-effective biologic access
Rating
Source: Amgen Biotechnology Singapore Pte Ltd
Description
Amgevita is a biosimilar adalimumab injection available as a solution in pre-filled autoinjectors and syringes. It is indicated for the treatment of various autoimmune diseases such as rheumatoid arthritis and plaque psoriasis. As of 2025, it includes high-concentration formulations (20mg/0.2ml and 40mg/0.4ml) and is eligible for government subsidies in Singapore under the Ministry of Health (MOH) Standard Drug List.
Best for
government subsidy eligibility, rheumatoid arthritis, high-concentration formulation and standard drug list access
Rating
Source: Amgen (Thailand) Limited
Description
Amgevita is a biosimilar to Humira, containing the active substance adalimumab. It is used as a biologic therapy for inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and plaque psoriasis. Available in Thailand as a solution for injection in 20 mg/0.4 ml and 40 mg/0.8 ml pre-filled syringes or autoinjectors, it is classified as a Special Controlled Drug that requires professional medical supervision for prescription and dispensing.
Best for
rheumatoid arthritis patients, biosimilar drug preference, chronic inflammation management and specialized biologic therapy
Rating
| Compare | Amgevita | Amgevita | Amgevita (adalimumab-atto) |
|---|---|---|---|
| Source | Amgen Biotechnology Singapore Pte Ltd | Amgen Biotechnology Singapore Pte Ltd | Amgen (Thailand) Limited |
| Description | Amgevita is a biosimilar to Humira (adalimumab) registered in Singapore for the treatment of various inflammatory conditions, including rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis. As an anti-inflammatory biologic, it provides a high-quality, cost-effective alternative for patients managing chronic autoimmune diseases. | Amgevita is a biosimilar adalimumab injection available as a solution in pre-filled autoinjectors and syringes. It is indicated for the treatment of various autoimmune diseases such as rheumatoid arthritis and plaque psoriasis. As of 2025, it includes high-concentration formulations (20mg/0.2ml and 40mg/0.4ml) and is eligible for government subsidies in Singapore under the Ministry of Health (MOH) Standard Drug List. | Amgevita is a biosimilar to Humira, containing the active substance adalimumab. It is used as a biologic therapy for inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and plaque psoriasis. Available in Thailand as a solution for injection in 20 mg/0.4 ml and 40 mg/0.8 ml pre-filled syringes or autoinjectors, it is classified as a Special Controlled Drug that requires professional medical supervision for prescription and dispensing. |
| Best for | rheumatoid arthritis patients, plaque psoriasis treatment and cost-effective biologic access | government subsidy eligibility, rheumatoid arthritis, high-concentration formulation and standard drug list access | rheumatoid arthritis patients, biosimilar drug preference, chronic inflammation management and specialized biologic therapy |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
If you want the most balanced option to start with, I recommend:
"Amgevita from Amgen Biotechnology Singapore Pte Ltd."
I picked this because Amgevita is a registered, cost-effective adalimumab biosimilar in Singapore that is often supported by government medication subsidies.